Chikungunya Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Post-Chikungunya Rheumatism - Rheumatology Follow-up of Patients After 15 Years
Condition: Chikungunya Intervention: Other: 15 years Follow-up group Sponsor: Centre Hospitalier Universitaire de la Réunion Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2021 Category: Research Source Type: clinical trials

Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine Candidate (VLA1553)
Condition: Chikungunya Virus Infection Intervention: Biological: VLA1553 Sponsor: Valneva Austria GmbH Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2021 Category: Research Source Type: clinical trials

Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy Adults
Condition: Chikungunya Virus Infection Intervention: Biological: Biological Vaccine VLA1553 Sponsor: Valneva Austria GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2021 Category: Research Source Type: clinical trials

Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria
Conditions: Travel-Related Illness; Malaria; Dengue; Chikungunya; Zika; SARS-CoV Infection; MERS; Influenza; Diarrhea Intervention: Other: Observational study Sponsors: Patricia Schlagenhauf; ETH Zurich; Swiss Tropical & Public Health Institute; University Hospital, Geneva; Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 17, 2020 Category: Research Source Type: clinical trials